SCIENTURE HOLDINGS, INC. Stockholders' Equity Attributable to Noncontrolling Interest
SCIENTURE HOLDINGS, INC. (SCNX) had Stockholders' Equity Attributable to Noncontrolling Interest of -$420.27 thousand as of 2022-12-31, per its 10-K filed 2024-04-22.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2024-04-22
- 2022-12-31: Stockholders' Equity Attributable to Noncontrolling Interest -$420.27K.
- 2022-09-30: Stockholders' Equity Attributable to Noncontrolling Interest -$42.43K.
- 2022-06-30: Stockholders' Equity Attributable to Noncontrolling Interest -$16.69K.
- 2022-03-31: Stockholders' Equity Attributable to Noncontrolling Interest $17.50K.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2022-12-31 | -$420.27K 10-K · filed 2024-04-22 |
| 2022-09-30 | -$42.43K 10-Q · filed 2022-11-07 |
| 2022-06-30 | -$16.69K 10-Q · filed 2022-07-25 |
| 2022-03-31 | $17.50K 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |